T9F-13078-83343 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-11
Dose 1 — Pfizer-BioNTech
2021-03-04
Dose 2 — Pfizer-BioNTech
2021-03-05
Registered in v-safe
2021-03-05
Survey response — days 1–6 daily, dose 2
MedDRA: Pregnancy, Vaginal haemorrhage — Feeling: Poor · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Free text: Spotting during pregnancy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-05
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-03-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-11	Pfizer-BioNTech
2	2021-03-04	Pfizer-BioNTech

Call center

1 call center case

1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-05

Systemic reaction (other): Spotting during pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Pregnancy	✓	✓	✓
SRO	Vaginal haemorrhage	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release